Santhera Pharmaceuticals Ag Headquarters
Looking for information about Santhera Pharmaceuticals Ag Headquarters? The links below have collected all the necessary data.
Santhera - Pharmaceutical Company: Medicine Research ...
- https://www.santhera.com/
- Pharmaceutical company in Switzerland committed to research & development of medicines for patients living with mitochondrial disorders & rare diseases. Home; ... You are now leaving the Santhera Pharmaceuticals corporate website and will visit the website of Santhera Germany.
Pharma Company - Pharmaceutical Product ... - SANTHERA
- https://www.santhera.com/about/about-santhera
- Santhera Pharmaceuticals was founded in September 2004 through the merger of two start-up biotech companies, MyoContract AG (Switzerland) and Graffinity Pharmaceuticals AG (Germany). Santhera’s headquarters are located in Pratteln, Switzerland (near Basel), with subsidiaries in Germany, the UK, Italy, the Netherlands, Liechtenstein, the US ...
Santhera Pharmaceuticals Company Profile: Stock ...
- https://pitchbook.com/profiles/company/40429-00
- Santhera Pharmaceuticals General Information Description. Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area which includes many orphan and niche indications with high unmet medical need.
Santhera Pharmaceuticals LinkedIn
- https://www.linkedin.com/company/santhera-pharmaceuticals-ltd
- Santhera Pharmaceuticals 9,113 followers on LinkedIn. We are dedicated to developing medicines to meet the needs of patients living with rare diseases. Santhera Pharmaceuticals (SIX: SANN) is ...Founded: 2004
Pharmaceutical & Medical Science - Santhera
- https://www.santhera.com/career/job-openings
- Jul 22, 2021 · Job openings. Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company focused on medical science and the development and commercialization of innovative pharmaceutical products for the treatment of rare neuromuscular and pulmonary diseases, areas of …
Santhera Pharmaceuticals
- https://www.santhera.de/assets/files/content/presentations/2021-02-16_Santhera_Presentation_final.pdf
- Santhera Pharmaceuticals Holding AG makes no representation (either express or implied) that the informationand opinions expressed in this presentation are accurate, complete or up to date. including any direct, indirect or consequential damages, which might be incurred in connection with the informationcontained in this presentation.
Santhera Pharmaceuticals Holding AG, SANN:SWX summary - …
- https://markets.ft.com/data/equities/tearsheet/summary?s=SANN:SWX
- Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company is involved in the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases. The Company’s products include Catena and Raxone brands, which are primarily implemented in the …Bid: 2.32
Santhera Pharmaceuticals Holding AG (S3F.F) - Yahoo
- https://finance.yahoo.com/quote/S3F.F/profile/
- Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare …
Santhera Pharmaceuticals Holding AG (SANN.SW) - Yahoo
- https://finance.yahoo.com/quote/SANN.SW
- The principal amount/denomination of the 2021/24 Bonds is CHF 3,375 per bond, with a conversion price of CHF 3.00 and a conversion ratio of 1,123 shares per bond. In addition, holders of the 2017 ...
Have you found Santhera Pharmaceuticals Ag Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.